Prevention of haemolytic disease of the newborn.
D000022:Abortion, Spontaneous; D000917:Antibody Formation; D004899:Erythroblastosis, Fetal / Q000517:prevention & control*; D005260:Female; D005331:Fetomaternal Transfusion; D006801:Humans; D007114:Immunization; D007136:Immunoglobulins / Q000627:therapeutic use; D010956:Plasmapheresis; D011247:Pregnancy; D012204:Rh-Hr Blood-Group System
D007136:Immunoglobulins; D012204:Rh-Hr Blood-Group System